Global Cord Blood (CO) Return on Assets ROA from the fourth quarter of 2022 to fourth quarter of 2021 and for the year 2022, Average High and Low, Fundamental Ratios from Mar 31 2022 to Mar 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Global Cord Blood Corp  (NYSE: CO)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Global Cord Blood's ROA from the fourth quarter of 2022 to the fourth quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Global Cord Blood's ROA in the fourth quarter of 2022?
Global Cord Blood Corp achieved a return on average assets (ROA) of 6.43 % in its fourth quarter of 2022, this is above CO's average return on assets of 4.52%.
Global Cord Blood Corp assets over the 12 months ending in its fourth quarter of 2022 are valued at $1,251 million

ROA has improved compared to 6.4% in the third quarter of 2022, due to net income growth.

However, within the Healthcare sector 151 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2022 from to 1349.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2022)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Mar 31 2021)
IV. Quarter
Y / Y Total Assets Change 6.59 % 18.35 % 16.64 % 18.35 % 19.99 %
Y / Y Net Income Change 2.01 % - - - 16.78 %
Net Income (TTM) in million 80 79 98 98 98
Return On Assets (TTM) 6.43 % 6.4 % 8.31 % 8.64 % 9.01 %
CO's Total Ranking # 1349 # # # # 1011
Total Assets (TTM) in million 1,316 1,207 1,274 1,207 1,234
Seq. Total Assets Change 9.01 % -5.26 % 5.55 % -2.23 % 21.04 %
Seq. Net Income Change - - - - 303.73 %

CO's 5 Years Annual ROA >> Back to CO Management Effectiveness >> Compare CO ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 18
Sector # 152
Overall # 1320

Return On Assets Statistics
High Average Low
7.23 %
4.52 %
1.94 %
(Mar 31 2013)   (Mar 31 2016)





Financial Statements
Global Cord Blood's Assets $ 1,316 million CO's Balance sheet
Global Cord Blood's Income $ 80 million Quarterly CO's Income Statement
CO's Income by Division See CO's Income by Division



Annual Return On Assets (Mar 31 2022)
FY 2022		 (Mar 31 2021)
FY 2021		 (Mar 31 2020)
FY 2020		 (Mar 31 2019)
FY 2019		 (Mar 31 2018)
FY 2018
Y / Y Total Assets Change 12.54 % 20.26 % 3.86 % 4.38 % 17.62 %
Total Assets in million 1,359 1,207 1,004 966 926
Y / Y Net Income Change 1.89 % 16.69 % 53.24 % 14.76 % 106.18 %
Net Income in million 79 78 66 43 38
Annual Return On Assets 5.82 % 6.43 % 6.62 % 4.49 % 4.08 %

CO's 5 Years Annual ROA >> Back to CO Management Effectiveness >> Compare CO ROA to its Competitors



Comment on CO's ROA in the fiscal year ending 2022
In the fiscal year 2022 ROA deteriorated to 5.82 %, despite annual net income growth of 1.89 % to $79.04 million, from $77.57 million a year ago, as CO's assets increase to $1,358.52 million, by 1.89 %.


More Return On Assets Ratios
CO's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CO's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CO's Competitors
Subscribers only: Roa for Global Cord Blood's Suppliers
Subscribers only: Return On Assets for CO's Customers

You may also want to know
CO's Roi CO's Inventory Turnover Ratio CO's Growth Rates CO's Dividend Comparisons
CO's Profitability Ratios CO's Asset Turnover Ratio CO's Dividend Growth
CO's Roe CO's Valuation Ratios CO's Financial Strength Ratios CO's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2022, within Healthcare Sector ROA
Zynex inc   17.45 %
Hologic Inc  17.08 %
Antares Pharma Inc   17.05 %
Cartesian Therapeutics Inc   16.95 %
Resmed Inc   16.33 %
Sunlink Health Systems Inc   16.13 %
Abcellera Biologics Inc   15.65 %
Progyny Inc   15.63 %
Hca Healthcare Inc   15.16 %
Zoetis Inc   14.91 %
Tivity Health Inc   14.71 %
Quest Diagnostics Inc  14.68 %
Biostax Corp  14.39 %
Merck and Co Inc   14.31 %
Xoma Royalty Corporation  14.12 %
Xencor Inc  14.08 %
Pfizer Inc  14.00 %
Meridian Bioscience Inc   13.67 %
Iradimed Corporation  13.48 %
United Therapeutics Corporation  13.46 %
Oramed Pharmaceuticals Inc  13.28 %
Medpace Holdings Inc   13.21 %
Eagle Pharmaceuticals inc   13.10 %
Utah Medical Products Inc  12.96 %
Eli Lilly And Company  12.79 %
Intuitive Surgical Inc   12.67 %
Atrion Corporation  12.58 %
Lifevantage Corp  12.37 %
Amphastar Pharmaceuticals Inc   12.36 %
Align Technology inc   12.31 %

Date modified: 2026-09-18T16:03:11+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.